Targeted agents for the treatment of hormone receptor–-positive, human epidermal growth factor receptor 2–negative metastatic breast cancer (HR+/HER2- MBC) with co-alterations in

Authors: Naomi Dempsey, Yolcar Chamorro, Priya Bhatt, Natasha Harpalani, Lydia Hodgson, Ana Cristina Sandoval-Leon, Lauren Carcas, Reagan Barnett, Cara Elmstrom, Manmeet Singh Ahluwalia, Reshma L. Mahtani

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e13084

Source: Full article

---

Abstract

e13084